PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 15(Suppl_5): 67-74 1995
© 1995 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, M.
Peritoneal Dialysis International, Vol 15, Issue 5_Suppl, S67-S74
Copyright © 1995 by International Society for Peritoneal Dialysis

Articles

Intraperitoneal amino acids: a therapy whose time has come?

MR Jones

Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois 60085-6730, USA.

In regard to the question posed in the title of this review, the answer is mixed. IPN is possible today but only on a limited basis and at high cost with uncertain benefit. A 1.1% amino acid dialysis solution for IPAA therapy is available in several European countries but has not yet been approved for use in the United States. When it becomes more widely available, IPAA should become an important tool, along with other types of therapy, for use in the maintenance of good nutritional status in PD patients.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1995 by Multimed Inc.